1 Market Overview

1.1 Product Overview and Scope of Nuclear Medicine Isotopes

1.2 Classification of Nuclear Medicine Isotopes by Type

1.2.1 Overview: Global Nuclear Medicine Isotopes Market Size by Type: 2020 Versus 2021 Versus 2026

1.2.2 Global Nuclear Medicine Isotopes Revenue Market Share by Type in 2020

1.2.3 Stable Isotopes

1.2.4 Radioisotopes

1.3 Global Nuclear Medicine Isotopes Market by Application

1.3.1 Overview: Global Nuclear Medicine Isotopes Market Size by Application: 2020 Versus 2021 Versus 2026

1.3.2 Nuclear Therapy

1.3.3 Equipment Radioactive Source

1.3.4 Diagnosis

1.4 Global Nuclear Medicine Isotopes Market Size & Forecast

1.5 Global Nuclear Medicine Isotopes Market Size and Forecast by Region

1.5.1 Global Nuclear Medicine Isotopes Market Size by Region: 2016 VS 2021 VS 2026

1.5.2 Global Nuclear Medicine Isotopes Market Size by Region, (2016-2021)

1.5.3 North America Nuclear Medicine Isotopes Market Size and Prospect (2016-2026)

1.5.4 Europe Nuclear Medicine Isotopes Market Size and Prospect (2016-2026)

1.5.5 Asia-Pacific Nuclear Medicine Isotopes Market Size and Prospect (2016-2026)

1.5.6 South America Nuclear Medicine Isotopes Market Size and Prospect (2016-2026)

1.5.7 Middle East and Africa Nuclear Medicine Isotopes Market Size and Prospect (2016-2026)

1.6 Market Drivers, Restraints and Trends

1.6.1 Nuclear Medicine Isotopes Market Drivers

1.6.2 Nuclear Medicine Isotopes Market Restraints

1.6.3 Nuclear Medicine Isotopes Trends Analysis

2 Company Profiles

2.1 NRG

2.1.1 NRG Details

2.1.2 NRG Major Business

2.1.3 NRG Nuclear Medicine Isotopes Product and Solutions

2.1.4 NRG Nuclear Medicine Isotopes Revenue, Gross Margin and Market Share (2019-2021)

2.1.5 NRG Recent Developments and Future Plans

2.2 NTP Radioisotopes

2.2.1 NTP Radioisotopes Details

2.2.2 NTP Radioisotopes Major Business

2.2.3 NTP Radioisotopes Nuclear Medicine Isotopes Product and Solutions

2.2.4 NTP Radioisotopes Nuclear Medicine Isotopes Revenue, Gross Margin and Market Share (2019-2021)

2.2.5 NTP Radioisotopes Recent Developments and Future Plans

2.3 JSC Isotope

2.3.1 JSC Isotope Details

2.3.2 JSC Isotope Major Business

2.3.3 JSC Isotope Nuclear Medicine Isotopes Product and Solutions

2.3.4 JSC Isotope Nuclear Medicine Isotopes Revenue, Gross Margin and Market Share (2019-2021)

2.3.5 JSC Isotope Recent Developments and Future Plans

2.4 ANSTO

2.4.1 ANSTO Details

2.4.2 ANSTO Major Business

2.4.3 ANSTO Nuclear Medicine Isotopes Product and Solutions

2.4.4 ANSTO Nuclear Medicine Isotopes Revenue, Gross Margin and Market Share (2019-2021)

2.4.5 ANSTO Recent Developments and Future Plans

2.5 IRE

2.5.1 IRE Details

2.5.2 IRE Major Business

2.5.3 IRE Nuclear Medicine Isotopes Product and Solutions

2.5.4 IRE Nuclear Medicine Isotopes Revenue, Gross Margin and Market Share (2019-2021)

2.5.5 IRE Recent Developments and Future Plans

2.6 Nordion

2.6.1 Nordion Details

2.6.2 Nordion Major Business

2.6.3 Nordion Nuclear Medicine Isotopes Product and Solutions

2.6.4 Nordion Nuclear Medicine Isotopes Revenue, Gross Margin and Market Share (2019-2021)

2.6.5 Nordion Recent Developments and Future Plans

2.7 Curium Pharma

2.7.1 Curium Pharma Details

2.7.2 Curium Pharma Major Business

2.7.3 Curium Pharma Nuclear Medicine Isotopes Product and Solutions

2.7.4 Curium Pharma Nuclear Medicine Isotopes Revenue, Gross Margin and Market Share (2019-2021)

2.7.5 Curium Pharma Recent Developments and Future Plans

2.8 Cambridge Isotope Laboratories

2.8.1 Cambridge Isotope Laboratories Details

2.8.2 Cambridge Isotope Laboratories Major Business

2.8.3 Cambridge Isotope Laboratories Nuclear Medicine Isotopes Product and Solutions

2.8.4 Cambridge Isotope Laboratories Nuclear Medicine Isotopes Revenue, Gross Margin and Market Share (2019-2021)

2.8.5 Cambridge Isotope Laboratories Recent Developments and Future Plans

2.9 Eckert & Ziegler Strahlen

2.9.1 Eckert & Ziegler Strahlen Details

2.9.2 Eckert & Ziegler Strahlen Major Business

2.9.3 Eckert & Ziegler Strahlen Nuclear Medicine Isotopes Product and Solutions

2.9.4 Eckert & Ziegler Strahlen Nuclear Medicine Isotopes Revenue, Gross Margin and Market Share (2019-2021)

2.9.5 Eckert & Ziegler Strahlen Recent Developments and Future Plans

2.10 Polatom

2.10.1 Polatom Details

2.10.2 Polatom Major Business

2.10.3 Polatom Nuclear Medicine Isotopes Product and Solutions

2.10.4 Polatom Nuclear Medicine Isotopes Revenue, Gross Margin and Market Share (2019-2021)

2.10.5 Polatom Recent Developments and Future Plans

2.11 Center of Molecular Research

2.11.1 Center of Molecular Research Details

2.11.2 Center of Molecular Research Major Business

2.11.3 Center of Molecular Research Nuclear Medicine Isotopes Product and Solutions

2.11.4 Center of Molecular Research Nuclear Medicine Isotopes Revenue, Gross Margin and Market Share (2019-2021)

2.11.5 Center of Molecular Research Recent Developments and Future Plans

2.12 China National Nuclear Corporation

2.12.1 China National Nuclear Corporation Details

2.12.2 China National Nuclear Corporation Major Business

2.12.3 China National Nuclear Corporation Nuclear Medicine Isotopes Product and Solutions

2.12.4 China National Nuclear Corporation Nuclear Medicine Isotopes Revenue, Gross Margin and Market Share (2019-2021)

2.12.5 China National Nuclear Corporation Recent Developments and Future Plans

2.13 Urenco

2.13.1 Urenco Details

2.13.2 Urenco Major Business

2.13.3 Urenco Nuclear Medicine Isotopes Product and Solutions

2.13.4 Urenco Nuclear Medicine Isotopes Revenue, Gross Margin and Market Share (2019-2021)

2.13.5 Urenco Recent Developments and Future Plans

2.14 LANL

2.14.1 LANL Details

2.14.2 LANL Major Business

2.14.3 LANL Nuclear Medicine Isotopes Product and Solutions

2.14.4 LANL Nuclear Medicine Isotopes Revenue, Gross Margin and Market Share (2019-2021)

2.14.5 LANL Recent Developments and Future Plans

2.15 Shanghai Engineering Research Center

2.15.1 Shanghai Engineering Research Center Details

2.15.2 Shanghai Engineering Research Center Major Business

2.15.3 Shanghai Engineering Research Center Nuclear Medicine Isotopes Product and Solutions

2.15.4 Shanghai Engineering Research Center Nuclear Medicine Isotopes Revenue, Gross Margin and Market Share (2019-2021)

2.15.5 Shanghai Engineering Research Center Recent Developments and Future Plans

2.16 IDB Holland

2.16.1 IDB Holland Details

2.16.2 IDB Holland Major Business

2.16.3 IDB Holland Nuclear Medicine Isotopes Product and Solutions

2.16.4 IDB Holland Nuclear Medicine Isotopes Revenue, Gross Margin and Market Share (2019-2021)

2.16.5 IDB Holland Recent Developments and Future Plans

2.17 NHTC

2.17.1 NHTC Details

2.17.2 NHTC Major Business

2.17.3 NHTC Nuclear Medicine Isotopes Product and Solutions

2.17.4 NHTC Nuclear Medicine Isotopes Revenue, Gross Margin and Market Share (2019-2021)

2.17.5 NHTC Recent Developments and Future Plans

2.18 Linde

2.18.1 Linde Details

2.18.2 Linde Major Business

2.18.3 Linde Nuclear Medicine Isotopes Product and Solutions

2.18.4 Linde Nuclear Medicine Isotopes Revenue, Gross Margin and Market Share (2019-2021)

2.18.5 Linde Recent Developments and Future Plans

2.19 ORNL

2.19.1 ORNL Details

2.19.2 ORNL Major Business

2.19.3 ORNL Nuclear Medicine Isotopes Product and Solutions

2.19.4 ORNL Nuclear Medicine Isotopes Revenue, Gross Margin and Market Share (2019-2021)

2.19.5 ORNL Recent Developments and Future Plans

2.20 SI Science

2.20.1 SI Science Details

2.20.2 SI Science Major Business

2.20.3 SI Science Nuclear Medicine Isotopes Product and Solutions

2.20.4 SI Science Nuclear Medicine Isotopes Revenue, Gross Margin and Market Share (2019-2021)

2.20.5 SI Science Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Nuclear Medicine Isotopes Revenue and Share by Players (2019-2021)

3.2 Market Concentration Rate

3.2.1 Top 3 Nuclear Medicine Isotopes Players Market Share

3.2.2 Top 10 Nuclear Medicine Isotopes Players Market Share

3.2.3 Market Competition Trend

3.3 Nuclear Medicine Isotopes Players Head Office, Products and Services Provided

3.4 Mergers & Acquisitions

3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Nuclear Medicine Isotopes Revenue and Market Share by Type (2016-2021)

4.2 Global Nuclear Medicine Isotopes Market Forecast by Type (2021-2026)

5 Market Size Segment by Application

5.1 Global Nuclear Medicine Isotopes Revenue Market Share by Application (2016-2021)

5.2 Nuclear Medicine Isotopes Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application

6.1 North America Nuclear Medicine Isotopes Revenue by Type (2016-2026)

6.2 North America Nuclear Medicine Isotopes Revenue by Application (2016-2026)

6.3 North America Nuclear Medicine Isotopes Market Size by Country

6.3.1 North America Nuclear Medicine Isotopes Revenue by Country (2016-2026)

6.3.2 United States Nuclear Medicine Isotopes Market Size and Forecast (2016-2026)

6.3.3 Canada Nuclear Medicine Isotopes Market Size and Forecast (2016-2026)

6.3.4 Mexico Nuclear Medicine Isotopes Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application

7.1 Europe Nuclear Medicine Isotopes Revenue by Type (2016-2026)

7.2 Europe Nuclear Medicine Isotopes Revenue by Application (2016-2026)

7.3 Europe Nuclear Medicine Isotopes Market Size by Country

7.3.1 Europe Nuclear Medicine Isotopes Revenue by Country (2016-2026)

7.3.2 Germany Nuclear Medicine Isotopes Market Size and Forecast (2016-2026)

7.3.3 France Nuclear Medicine Isotopes Market Size and Forecast (2016-2026)

7.3.4 United Kingdom Nuclear Medicine Isotopes Market Size and Forecast (2016-2026)

7.3.5 Russia Nuclear Medicine Isotopes Market Size and Forecast (2016-2026)

7.3.6 Italy Nuclear Medicine Isotopes Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Nuclear Medicine Isotopes Revenue by Type (2016-2026)

8.2 Asia-Pacific Nuclear Medicine Isotopes Revenue by Application (2016-2026)

8.3 Asia-Pacific Nuclear Medicine Isotopes Market Size by Region

8.3.1 Asia-Pacific Nuclear Medicine Isotopes Revenue by Region (2016-2026)

8.3.2 China Nuclear Medicine Isotopes Market Size and Forecast (2016-2026)

8.3.3 Japan Nuclear Medicine Isotopes Market Size and Forecast (2016-2026)

8.3.4 South Korea Nuclear Medicine Isotopes Market Size and Forecast (2016-2026)

8.3.5 India Nuclear Medicine Isotopes Market Size and Forecast (2016-2026)

8.3.6 Southeast Asia Nuclear Medicine Isotopes Market Size and Forecast (2016-2026)

8.3.7 Australia Nuclear Medicine Isotopes Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application

9.1 South America Nuclear Medicine Isotopes Revenue by Type (2016-2026)

9.2 South America Nuclear Medicine Isotopes Revenue by Application (2016-2026)

9.3 South America Nuclear Medicine Isotopes Market Size by Country

9.3.1 South America Nuclear Medicine Isotopes Revenue by Country (2016-2026)

9.3.2 Brazil Nuclear Medicine Isotopes Market Size and Forecast (2016-2026)

9.3.3 Argentina Nuclear Medicine Isotopes Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Nuclear Medicine Isotopes Revenue by Type (2016-2026)

10.2 Middle East & Africa Nuclear Medicine Isotopes Revenue by Application (2016-2026)

10.3 Middle East & Africa Nuclear Medicine Isotopes Market Size by Country

10.3.1 Middle East & Africa Nuclear Medicine Isotopes Revenue by Country (2016-2026)

10.3.2 Turkey Nuclear Medicine Isotopes Market Size and Forecast (2016-2026)

10.3.3 Saudi Arabia Nuclear Medicine Isotopes Market Size and Forecast (2016-2026)

10.3.4 UAE Nuclear Medicine Isotopes Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Nuclear Medicine Isotopes Revenue by Type, (USD Million), 2020 VS 2021 VS 2026

Table 2. Global Nuclear Medicine Isotopes Revenue by Application, (USD Million), 2020 VS 2021 VS 2026

Table 3. Global Market Nuclear Medicine Isotopes Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)

Table 4. Global Nuclear Medicine Isotopes Revenue (USD Million) by Region (2016-2021)

Table 5. Global Nuclear Medicine Isotopes Revenue Market Share by Region (2021-2026)

Table 6. NRG Corporate Information, Head Office, and Major Competitors

Table 7. NRG Major Business

Table 8. NRG Nuclear Medicine Isotopes Product and Solutions

Table 9. NRG Nuclear Medicine Isotopes Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 10. NTP Radioisotopes Corporate Information, Head Office, and Major Competitors

Table 11. NTP Radioisotopes Major Business

Table 12. NTP Radioisotopes Nuclear Medicine Isotopes Product and Solutions

Table 13. NTP Radioisotopes Nuclear Medicine Isotopes Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 14. JSC Isotope Corporate Information, Head Office, and Major Competitors

Table 15. JSC Isotope Major Business

Table 16. JSC Isotope Nuclear Medicine Isotopes Product and Solutions

Table 17. JSC Isotope Nuclear Medicine Isotopes Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 18. ANSTO Corporate Information, Head Office, and Major Competitors

Table 19. ANSTO Major Business

Table 20. ANSTO Nuclear Medicine Isotopes Product and Solutions

Table 21. ANSTO Nuclear Medicine Isotopes Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 22. IRE Corporate Information, Head Office, and Major Competitors

Table 23. IRE Major Business

Table 24. IRE Nuclear Medicine Isotopes Product and Solutions

Table 25. IRE Nuclear Medicine Isotopes Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 26. Nordion Corporate Information, Head Office, and Major Competitors

Table 27. Nordion Major Business

Table 28. Nordion Nuclear Medicine Isotopes Product and Solutions

Table 29. Nordion Nuclear Medicine Isotopes Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 30. Curium Pharma Corporate Information, Head Office, and Major Competitors

Table 31. Curium Pharma Major Business

Table 32. Curium Pharma Nuclear Medicine Isotopes Product and Solutions

Table 33. Curium Pharma Nuclear Medicine Isotopes Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 34. Cambridge Isotope Laboratories Corporate Information, Head Office, and Major Competitors

Table 35. Cambridge Isotope Laboratories Major Business

Table 36. Cambridge Isotope Laboratories Nuclear Medicine Isotopes Product and Solutions

Table 37. Cambridge Isotope Laboratories Nuclear Medicine Isotopes Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 38. Eckert & Ziegler Strahlen Corporate Information, Head Office, and Major Competitors

Table 39. Eckert & Ziegler Strahlen Major Business

Table 40. Eckert & Ziegler Strahlen Nuclear Medicine Isotopes Product and Solutions

Table 41. Eckert & Ziegler Strahlen Nuclear Medicine Isotopes Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 42. Polatom Corporate Information, Head Office, and Major Competitors

Table 43. Polatom Major Business

Table 44. Polatom Nuclear Medicine Isotopes Product and Solutions

Table 45. Polatom Nuclear Medicine Isotopes Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 46. Center of Molecular Research Corporate Information, Head Office, and Major Competitors

Table 47. Center of Molecular Research Major Business

Table 48. Center of Molecular Research Nuclear Medicine Isotopes Product and Solutions

Table 49. Center of Molecular Research Nuclear Medicine Isotopes Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 50. China National Nuclear Corporation Corporate Information, Head Office, and Major Competitors

Table 51. China National Nuclear Corporation Major Business

Table 52. China National Nuclear Corporation Nuclear Medicine Isotopes Product and Solutions

Table 53. China National Nuclear Corporation Nuclear Medicine Isotopes Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 54. Urenco Corporate Information, Head Office, and Major Competitors

Table 55. Urenco Major Business

Table 56. Urenco Nuclear Medicine Isotopes Product and Solutions

Table 57. Urenco Nuclear Medicine Isotopes Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 58. LANL Corporate Information, Head Office, and Major Competitors

Table 59. LANL Major Business

Table 60. LANL Nuclear Medicine Isotopes Product and Solutions

Table 61. LANL Nuclear Medicine Isotopes Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 62. Shanghai Engineering Research Center Corporate Information, Head Office, and Major Competitors

Table 63. Shanghai Engineering Research Center Major Business

Table 64. Shanghai Engineering Research Center Nuclear Medicine Isotopes Product and Solutions

Table 65. Shanghai Engineering Research Center Nuclear Medicine Isotopes Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 66. IDB Holland Corporate Information, Head Office, and Major Competitors

Table 67. IDB Holland Major Business

Table 68. IDB Holland Nuclear Medicine Isotopes Product and Solutions

Table 69. IDB Holland Nuclear Medicine Isotopes Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 70. NHTC Corporate Information, Head Office, and Major Competitors

Table 71. NHTC Major Business

Table 72. NHTC Nuclear Medicine Isotopes Product and Solutions

Table 73. NHTC Nuclear Medicine Isotopes Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 74. Linde Corporate Information, Head Office, and Major Competitors

Table 75. Linde Major Business

Table 76. Linde Nuclear Medicine Isotopes Product and Solutions

Table 77. Linde Nuclear Medicine Isotopes Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 78. ORNL Corporate Information, Head Office, and Major Competitors

Table 79. ORNL Major Business

Table 80. ORNL Nuclear Medicine Isotopes Product and Solutions

Table 81. ORNL Nuclear Medicine Isotopes Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 82. SI Science Corporate Information, Head Office, and Major Competitors

Table 83. SI Science Major Business

Table 84. SI Science Nuclear Medicine Isotopes Product and Solutions

Table 85. SI Science Nuclear Medicine Isotopes Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 86. Global Nuclear Medicine Isotopes Revenue (USD Million) by Players (2019-2021)

Table 87. Global Nuclear Medicine Isotopes Revenue Share by Players (2019-2021)

Table 88. Breakdown of Nuclear Medicine Isotopes by Company Type (Tier 1, Tier 2 and Tier 3)

Table 89. Nuclear Medicine Isotopes Players Head Office, Products and Services Provided

Table 90. Nuclear Medicine Isotopes Mergers & Acquisitions in the Past Five Years

Table 91. Nuclear Medicine Isotopes New Entrants and Expansion Plans

Table 92. Global Nuclear Medicine Isotopes Revenue (USD Million) by Type (2016-2021)

Table 93. Global Nuclear Medicine Isotopes Revenue Share by Type (2016-2021)

Table 94. Global Nuclear Medicine Isotopes Revenue Forecast by Type (2021-2026)

Table 95. Global Nuclear Medicine Isotopes Revenue by Application (2016-2021)

Table 96. Global Nuclear Medicine Isotopes Revenue Forecast by Application (2021-2026)

Table 97. North America Nuclear Medicine Isotopes Revenue by Type (2016-2021) & (USD Million)

Table 98. North America Nuclear Medicine Isotopes Revenue by Type (2021-2026) & (USD Million)

Table 99. North America Nuclear Medicine Isotopes Revenue by Application (2016-2021) & (USD Million)

Table 100. North America Nuclear Medicine Isotopes Revenue by Application (2021-2026) & (USD Million)

Table 101. North America Nuclear Medicine Isotopes Revenue by Country (2016-2021) & (USD Million)

Table 102. North America Nuclear Medicine Isotopes Revenue by Country (2021-2026) & (USD Million)

Table 103. Europe Nuclear Medicine Isotopes Revenue by Type (2016-2021) & (USD Million)

Table 104. Europe Nuclear Medicine Isotopes Revenue by Type (2021-2026) & (USD Million)

Table 105. Europe Nuclear Medicine Isotopes Revenue by Application (2016-2021) & (USD Million)

Table 106. Europe Nuclear Medicine Isotopes Revenue by Application (2021-2026) & (USD Million)

Table 107. Europe Nuclear Medicine Isotopes Revenue by Country (2016-2021) & (USD Million)

Table 108. Europe Nuclear Medicine Isotopes Revenue by Country (2021-2026) & (USD Million)

Table 109. Asia-Pacific Nuclear Medicine Isotopes Revenue by Type (2016-2021) & (USD Million)

Table 110. Asia-Pacific Nuclear Medicine Isotopes Revenue by Type (2021-2026) & (USD Million)

Table 111. Asia-Pacific Nuclear Medicine Isotopes Revenue by Application (2016-2021) & (USD Million)

Table 112. Asia-Pacific Nuclear Medicine Isotopes Revenue by Application (2021-2026) & (USD Million)

Table 113. Asia-Pacific Nuclear Medicine Isotopes Revenue by Region (2016-2021) & (USD Million)

Table 114. Asia-Pacific Nuclear Medicine Isotopes Revenue by Region (2021-2026) & (USD Million)

Table 115. South America Nuclear Medicine Isotopes Revenue by Type (2016-2021) & (USD Million)

Table 116. South America Nuclear Medicine Isotopes Revenue by Type (2021-2026) & (USD Million)

Table 117. South America Nuclear Medicine Isotopes Revenue by Application (2016-2021) & (USD Million)

Table 118. South America Nuclear Medicine Isotopes Revenue by Application (2021-2026) & (USD Million)

Table 119. South America Nuclear Medicine Isotopes Revenue by Country (2016-2021) & (USD Million)

Table 120. South America Nuclear Medicine Isotopes Revenue by Country (2021-2026) & (USD Million)

Table 121. Middle East & Africa Nuclear Medicine Isotopes Revenue by Type (2016-2021) & (USD Million)

Table 122. Middle East & Africa Nuclear Medicine Isotopes Revenue by Type (2021-2026) & (USD Million)

Table 123. Middle East & Africa Nuclear Medicine Isotopes Revenue by Application (2016-2021) & (USD Million)

Table 124. Middle East & Africa Nuclear Medicine Isotopes Revenue by Application (2021-2026) & (USD Million)

Table 125. Middle East & Africa Nuclear Medicine Isotopes Revenue by Country (2016-2021) & (USD Million)

Table 126. Middle East & Africa Nuclear Medicine Isotopes Revenue by Country (2021-2026) & (USD Million)

List of Figures

Figure 1. Nuclear Medicine Isotopes Picture

Figure 2. Global Nuclear Medicine Isotopes Revenue Market Share by Type in 2020

Figure 3. Stable Isotopes

Figure 4. Radioisotopes

Figure 5. Nuclear Medicine Isotopes Revenue Market Share by Application in 2020

Figure 6. Nuclear Therapy Picture

Figure 7. Equipment Radioactive Source Picture

Figure 8. Diagnosis Picture

Figure 9. Global Nuclear Medicine Isotopes Revenue, (USD Million): 2020 VS 2021 VS 2026

Figure 10. Global Nuclear Medicine Isotopes Revenue and Forecast (2016-2026) & (USD Million)

Figure 11. Global Nuclear Medicine Isotopes Revenue Market Share by Region (2016-2026)

Figure 12. Global Nuclear Medicine Isotopes Revenue Market Share by Region in 2020

Figure 13. North America Nuclear Medicine Isotopes Revenue (USD Million) and Growth Rate (2016-2026)

Figure 14. Europe Nuclear Medicine Isotopes Revenue (USD Million) and Growth Rate (2016-2026)

Figure 15. Asia-Pacific Nuclear Medicine Isotopes Revenue (USD Million) and Growth Rate (2016-2026)

Figure 16. South America Nuclear Medicine Isotopes Revenue (USD Million) and Growth Rate (2016-2026)

Figure 17. Middle East and Africa Nuclear Medicine Isotopes Revenue (USD Million) and Growth Rate (2016-2026)

Figure 18. Nuclear Medicine Isotopes Market Drivers

Figure 19. Nuclear Medicine Isotopes Market Restraints

Figure 20. Nuclear Medicine Isotopes Market Trends

Figure 21. NRG Recent Developments and Future Plans

Figure 22. NTP Radioisotopes Recent Developments and Future Plans

Figure 23. JSC Isotope Recent Developments and Future Plans

Figure 24. ANSTO Recent Developments and Future Plans

Figure 25. IRE Recent Developments and Future Plans

Figure 26. Nordion Recent Developments and Future Plans

Figure 27. Curium Pharma Recent Developments and Future Plans

Figure 28. Cambridge Isotope Laboratories Recent Developments and Future Plans

Figure 29. Eckert & Ziegler Strahlen Recent Developments and Future Plans

Figure 30. Polatom Recent Developments and Future Plans

Figure 31. Center of Molecular Research Recent Developments and Future Plans

Figure 32. China National Nuclear Corporation Recent Developments and Future Plans

Figure 33. Urenco Recent Developments and Future Plans

Figure 34. LANL Recent Developments and Future Plans

Figure 35. Shanghai Engineering Research Center Recent Developments and Future Plans

Figure 36. IDB Holland Recent Developments and Future Plans

Figure 37. NHTC Recent Developments and Future Plans

Figure 38. Linde Recent Developments and Future Plans

Figure 39. ORNL Recent Developments and Future Plans

Figure 40. SI Science Recent Developments and Future Plans

Figure 41. Global Nuclear Medicine Isotopes Revenue Share by Players in 2020

Figure 42. Nuclear Medicine Isotopes Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 43. Global Top 3 Players Nuclear Medicine Isotopes Revenue Market Share in 2020

Figure 44. Global Top 10 Players Nuclear Medicine Isotopes Revenue Market Share in 2020

Figure 45. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)

Figure 46. Global Nuclear Medicine Isotopes Revenue Share by Type in 2020

Figure 47. Global Nuclear Medicine Isotopes Market Share Forecast by Type (2021-2026)

Figure 48. Global Nuclear Medicine Isotopes Revenue Share by Application in 2020

Figure 49. Global Nuclear Medicine Isotopes Market Share Forecast by Application (2021-2026)

Figure 50. North America Nuclear Medicine Isotopes Sales Market Share by Type (2016-2026)

Figure 51. North America Nuclear Medicine Isotopes Sales Market Share by Application (2016-2026)

Figure 52. North America Nuclear Medicine Isotopes Revenue Market Share by Country (2016-2026)

Figure 53. United States Nuclear Medicine Isotopes Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 54. Canada Nuclear Medicine Isotopes Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 55. Mexico Nuclear Medicine Isotopes Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 56. Europe Nuclear Medicine Isotopes Sales Market Share by Type (2016-2026)

Figure 57. Europe Nuclear Medicine Isotopes Sales Market Share by Application (2016-2026)

Figure 58. Europe Nuclear Medicine Isotopes Revenue Market Share by Country (2016-2026)

Figure 59. Germany Nuclear Medicine Isotopes Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 60. France Nuclear Medicine Isotopes Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 61. United Kingdom Nuclear Medicine Isotopes Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 62. Russia Nuclear Medicine Isotopes Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 63. Italy Nuclear Medicine Isotopes Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 64. Asia-Pacific Nuclear Medicine Isotopes Sales Market Share by Type (2016-2026)

Figure 65. Asia-Pacific Nuclear Medicine Isotopes Sales Market Share by Application (2016-2026)

Figure 66. Asia-Pacific Nuclear Medicine Isotopes Revenue Market Share by Region (2016-2026)

Figure 67. China Nuclear Medicine Isotopes Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 68. Japan Nuclear Medicine Isotopes Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 69. South Korea Nuclear Medicine Isotopes Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 70. India Nuclear Medicine Isotopes Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 71. Southeast Asia Nuclear Medicine Isotopes Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 72. Australia Nuclear Medicine Isotopes Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 73. South America Nuclear Medicine Isotopes Sales Market Share by Type (2016-2026)

Figure 74. South America Nuclear Medicine Isotopes Sales Market Share by Application (2016-2026)

Figure 75. South America Nuclear Medicine Isotopes Revenue Market Share by Country (2016-2026)

Figure 76. Brazil Nuclear Medicine Isotopes Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 77. Argentina Nuclear Medicine Isotopes Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 78. Middle East and Africa Nuclear Medicine Isotopes Sales Market Share by Type (2016-2026)

Figure 79. Middle East and Africa Nuclear Medicine Isotopes Sales Market Share by Application (2016-2026)

Figure 80. Middle East and Africa Nuclear Medicine Isotopes Revenue Market Share by Country (2016-2026)

Figure 81. Turkey Nuclear Medicine Isotopes Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 82. Saudi Arabia Nuclear Medicine Isotopes Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 83. UAE Nuclear Medicine Isotopes Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 84. Methodology

Figure 85. Research Process and Data Source